Zinnat 125 mg/5 ml granule za oralnu suspenziju
| Name | Zinnat 125 mg/5 ml granule za oralnu suspenziju |
|---|---|
| Marketing Authorisation Number | HR-H-715978020 |
| Active Substance | cefuroksimaksetil |
| Composition | 5 ml suspenzije sadrži 125 mg cefuroksima u obliku cefuroksimaksetila |
| Pharmaceutical Form | granule za oralnu suspenziju |
| Manufacturer | GlaxoSmithKline Trading Services Limited, Dublin 24, Irska
Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 31.05.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/715 |
| Registration Number | 381-12-01/70-23-36 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01DC02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
